Racial Disparity Seen in Childbirth-Related Readmission

This article originally appeared here.
Share this content:
Racial Disparity Seen in Childbirth-Related Readmission
Racial Disparity Seen in Childbirth-Related Readmission

TUESDAY, Oct. 13, 2015 (HealthDay News) -- Black and Hispanic women have significantly higher readmission rates than white women after childbirth, according to a study published online Oct. 5 in Obstetrics & Gynecology.

Robert H. Aseltine Jr., Ph.D., from UConn Health in Farmington, Connecticut, and colleagues analyzed hospital discharge data (from 2005 to 2012) contained in a statewide database maintained by the Connecticut Department of Public Health for patients admitted for vaginal delivery without complication (167,857 women) and cesarean delivery without complication (75,552 women).

The researchers found that 30-day readmission rates were significantly higher among black (28.9/1,000) and Hispanic women (21.4/1,000) compared with white women (12.9/1,000) after cesarean delivery. Similarly higher rates of readmission were observed for vaginal delivery (black women, 14.6/1,000; Hispanic women, 10.7/1,000; white women, 7.5/1,000). For patients covered by Medicaid, rates of 30-day readmission were significantly higher (odds ratio, 1.27-1.3). Racial and ethnic differences in the odds of readmission were not substantially reduced even when the researchers controlled for patient socioeconomic status, comorbidities, and payer.

"Significant racial and ethnic disparities in readmissions were observed for procedures related to childbirth using a statewide database capturing all payers across all acute care hospital settings," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »